Live Ludwig Cancer Research News with Latest Updates

Live Ludwig Cancer Research news and developments with the latest updates. Check out current Ludwig Cancer Research news stories and find out what happened, what is going on with Ludwig Cancer Research. Recent news updates about Ludwig Cancer Research
Ludwig Cancer Research study reveals how circular ecDNA is generated and drives drug resistance in cancer
Ludwig Lausanne receives Team Science Award from Society for Immunotherapy of Cancer
A better test for tumor-targeting of CAR-T therapies
Two companies founded by Ludwig researchers acquired by Exact Sciences
Ludwig MIT researcher Angelika Amon passes away
Former Ludwig Board Member Pierre Languetin passes away
Ludwig study finds a common nutritional supplement might boost effects of cancer immunotherapy
Toward a personalized cancer nanovaccine
Ludwig study shows how loss of a single gene fuels a childhood brain cancer
Former Ludwig Sydney Director and renowned physician-researcher Martin Tattersall passes away
Ludwig Chicago study identifies a novel drug target for control of cancer metastasis
Ludwig study shows free-floating circles of DNA are common across cancers and drive poor patient outcomes
Ludwig Lausanne’s Ping-Chih Ho named Lloyd J. Old STAR researcher
Ludwig San Diego study identifies deadly genetic synergy in cancer cells and shows it might be exploited
Ludwig Cancer Research mourns death of Sanjiv Sam Gambhir
Ludwig Cancer Research study finds reprogramming of immune cells enhances effects of radiotherapy
Juanita L. Merchant appointed to Ludwig Institute’s Scientific Advisory Committee
Epigenetics researcher Yang Shi appointed Member of Ludwig Oxford
New technique may quickly and accurately predict effective therapies in solid tumors
Ludwig Cancer Research technology to be commercialized for liquid biopsies
Ludwig Lausanne study charts immune landscape of multiple brain cancers
Ludwig Johns Hopkins researchers to clinically evaluate use of blood pressure drug to prevent serious complication
Five Ludwig Cancer Research scientists named Fellows of American Association for Cancer Research
Three Ludwig Cancer Research scientists named Fellows of American Association for Cancer Research
Ludwig Oxford Director Xin Lu elected to Royal Society
Ludwig Harvard Co-Director George Demetri wins Karnofsky Award
Ludwig MSK study reveals bile metabolite of gut microbes boosts immune cells that can help contain
Nanosensors for early detection of lung cancer
Ludwig Cancer Research statement on COVID-19
Targeting turncoat immune cells to treat cancer
Dismantling drug resistance in colorectal cancer
Building a safer CAR-T therapy
Robert Schreiber joins Ludwig Institute’s Scientific Advisory Committee
A single number to mark deadliest cancer cells
Douglas Hanahan appointed Distinguished Scholar of Ludwig Institute for Cancer Research
Ping-Chih Ho appointed Associate Member of Ludwig Institute for Cancer Research
Vaccitech Oncology Limited and Ludwig Institute for Cancer Research enter collaboration with Cancer
Ludwig researchers engineer car-t cells to resist exhaustion, attack solid tumors in mice
Ludwig Lausanne’s Ping-Chih Ho named an embo young investigator
A new pathway for lung cancer treatment
Ludwig Harvard study reveals how non-mutational changes to genome drive a type of cancer
Ludwig researchers develop machine learning tool to refine personalized immunotherapy
Ludwig Oxford’s Sir Peter Ratcliffe wins Nobel Prize
Aggressive brain cancers tap into neural wiring to thrive
Alexandra Johnson appointed to Board of Ludwig Institute for Cancer Research
Test promises to improve identification of precancerous pancreatic cysts
Ludwig study establishes cancer-driving role of enzyme that alters membrane of cancer cells
Ludwig Stanford researchers borrow from sports playbook to predict cancer outcomes